Labcorp (LH)
NYSEHealth CareMedical - Diagnostics & ResearchSnapshot 2026-11-04
$367.79+3.92%
Close 2026-11-04 · 1-day change
NYSEHealth CareMedical - Diagnostics & ResearchSnapshot 2026-11-04
QuarterlyIQ Insights · LH
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | 4.4% |
| Our one-year growth estimate | diamond | 6.1% |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-11-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
A larger daily loss that occurred about once in every 20 trading days.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Growth built into the price is above our model estimate.
The price assumes 1.8 percentage points less one-year growth.
The one-year revenue growth assumption on Valuation.
Model as of 2026-11-04 · Compared with 12 industry peers · Company calendar date is not available
LH — dividend update
Dated 2026-10-21
Regulation FD Disclosure. Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced on October 21, 2026, that its Board of Directors has declared a cash dividend in the amount of $0.72 per share of common stock. The dividend will be payable on December 11, 2026, to stockholders of record as of the close of business on November 24, 2026 . A copy of the press release is furnished as Exhibit 99.1 hereto and incorporated by reference herein.
Why it matters: Labcorp's Q3 revenue grew 6.9%, while Health Care is in a maturing phase with growth easing. Faster company growth would stand out against that sector trend.
Supportive ifA later quarterly report shows Labcorp revenue growth above 6.9% year over year.
Worry ifA later quarterly report shows revenue growth below 6.9% year over year.
Why it matters: Labcorp raised its 2026 adjusted EPS range to $18.30–$18.70. A result above the low end would support its stronger earnings trend.
Supportive ifLabcorp reports 2026 adjusted EPS above $18.30, the bottom of its updated range.
Worry ifLabcorp reports 2026 adjusted EPS below $18.30 or cuts its range before year-end.
Why it matters: The BioReference, Myriad Prenatal Health, and Millennium deals could add to Labcorp's testing services. Each deal still needs approval and usual closing steps.
Supportive ifLabcorp reports that all three announced deals have closed. It has not disclosed any deal termination.
Worry ifLabcorp reports that any of the three deals was terminated or did not close.
Why it matters: Labcorp said preliminary CMS rates could bring steep annual cuts. Final rates or a change in the proposal could affect lab revenue.
Watch forCMS changes its early 2027–2029 rates. This lowers or removes the steep yearly cuts Labcorp cited.
Also watch forCMS keeps rates that Labcorp says would impose steep annual payment cuts for 2027–2029.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$83 on $10,000 · ±0.8% | How much price usually moves either way. |
| Bad day | $211 loss on $10,000 · 2.1% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $1,341 loss on $10,000 · 13.4% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.